|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/5575 | (2006.01) |
| A61P 25/00 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 1864666 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06730774.4 |
| Date of filing the European patent application | 2006-03-31 | |
| (97) | Date of publication of the European application | 2007-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-15 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (86) | Number | PCT/JP2006/306826 |
| Date | 2006-03-31 |
| (87) | Number | WO 2006/106915 |
| Date | 2006-10-12 |
| (30) | Number | Date | Country code |
| 2005100348 | 2005-03-31 | JP |
| (72) |
ISHIDA, Naruhiro, JP
SHIMAZAKI, Atsushi, JP
|
| (73) |
SANTEN PHARMACEUTICAL CO., LTD.,
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533-8651,
JP
AGC Inc., 5-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JP |
| (74) |
Gediminas PRANEVIČIUS,
Advokatų profesinė bendrija IP FORMA, Užupio g. 30, LT-01203 Vilnius,
LT
|
| (54) | Tinklainės nervinės ląstelės apsauginis agentas, turintis prostaglandino F2 alfa darinį kaip aktyvų ingredientą |
| PROTECTIVE AGENT FOR RETINAL NEURONAL CELL CONTAINING PROSTAGLANDIN F2 ALPHA DERIVATIVE AS ACTIVE INGREDIENT |
| Payment date | Validity (years) | Amount | |
| 2018-02-23 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-03-31 |